Catalent
CTLT
#1594
Rank
HK$84.52 B
Marketcap
HK$465.68
Share price
-0.05%
Change (1 day)
71.03%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Earnings for Catalent (CTLT)

Earnings in 2024 (TTM): -HK$6.06 Billion

According to Catalent's latest financial reports the company's current earnings are HK$4.38 Billion. In 2023 the company made an earning of -HK$9.39 Billion a decrease over its 2022 earnings that were of HK$5.03 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Catalent from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$6.06 Billion-35.47%
2023 -HK$9.39 Billion-286.27%
2022 HK$5.03 B-25.81%
2021 HK$6.78 B77.66%
2020 HK$3.82 B62.46%
2019 HK$2.35 B10.64%
2018 HK$2.12 B18.66%
2017 HK$1.79 B9.14%
2016 HK$1.64 B-15.11%
2015 HK$1.93 B15.35%
2014 HK$1.67 B10.45%
2013 HK$1.51 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.29 B-104.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.19 Billion-96.99%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.31 B-138.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-HK$0.46 Billion-92.50%๐Ÿ‡บ๐Ÿ‡ธ USA